Comparison Chart Vanda Pharmaceuticals Inc.
Equities
VNDA
US9216591084
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.405 USD | -0.07% |
|
-8.67% | -15.82% |
| 01-08 | Wall Street Wavers Amid Trump's Defense Budget Plans, Driving Muted Premarket Action for US Equity Futures | MT |
| 01-08 | Vanda Pharmaceuticals Says FDA Rejects Hetlioz as Jet Lag Treatment | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VANDA PHARMACEUTICALS INC. | Bio Therapeutic Drugs | +0.20% | -8.67% | -15.82% | +63.91% | -46.96% | 438M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- VNDA Stock
- Charts Vanda Pharmaceuticals Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition